YOLFTbeta
F7

Gaush Meditech Ltd

F7Y · F · Healthcare / Medical Devices

0.545EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.545
Open0.545
Day Range0.545 – 0.545
52-Week Range0.476 – 1.00
Volume0
Market Cap73.94M
P/E (TTM)7.14
Forward P/E0.00
EPS0.07
Dividend Yield0.00%
Beta0.01
50-Day Avg0.5062
200-Day Avg0.5947

About

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. The company was founded in 1998 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Xinwei Liu
  • Employees890
  • HeadquartersBuilding A, Zhonghui Plaza, Beijing, China, Germany
  • Websitehttps://www.gaush.com

Leadership

  • Mr. Tieta GaoExecutive Chairman · b. 1965
  • Mr. Xinwei LiuExecutive Director & CEO · b. 1982
  • Mr. Jianjun ZhangHonorary President & Executive Director · b. 1964
  • Ms. Wenqi LiCFO & Executive Director · b. 1974
  • Mr. Xinli ZhaoExecutive Director & Chief Compliance Officer · b. 1967
  • Dr. Alexey Nikolaevich SimonovChief Technology Officer · b. 1972
  • Ms. Shui Bing Leung A.C.S.Joint Company Secretary · b. 1977
  • Mr. Bo ZhangJoint Company Secretary · b. 1986

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.30B1.25B1.41B1.43B1.38B
Growth (%)--3.42%+12.16%+1.58%-3.37%
Cost of Revenue688.75M628.45M714.64M765.01M747.16M
Gross Profit609.47M625.34M691.60M663.39M633.20M
Gross Margin46.95%49.88%49.18%46.44%45.87%
Operating Expense330.59M360.53M412.44M437.37M488.04M
Operating Income278.88M264.81M279.15M226.01M145.16M
Operating Margin21.48%21.12%19.85%15.82%10.52%
EBITDA--166.66M374.31M273.94M225.13M
EBITDA Margin--13.29%26.62%19.18%16.31%
Net Income-190.45M-349.62M173.52M92.39M96.19M
Net Income Margin-14.67%-27.89%12.34%6.47%6.97%
R&D23.51M41.09M52.88M78.42M92.58M
R&D as % of Total Revenue1.81%3.28%3.76%5.49%6.71%
Interest Expense83.53M42.68M50.61M36.71M19.59M
Interest Expense % of Total Revenue6.43%3.40%3.60%2.57%1.42%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.43B2.72B2.84B2.57B2.62B
Total Liabilities3.06B1.23B1.15B978.12M927.15M
Total Equity-656.43M1.47B1.68B1.58B1.69B
Cash609.00M721.52M618.70M421.44M437.66M
Net Debt307.90M--86.29M12.66M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow164.49M234.42M249.04M107.78M144.23M
Capital Expenditure28.05M48.01M45.60M81.21M33.76M
Free Cash Flow136.44M186.41M203.44M26.57M110.47M
FCF to OCF82.95%79.52%81.69%24.65%76.59%

Key Statistics & Ratios

Market Cap73.94M
Enterprise Value80.21M
Trailing P/E7.14
Forward P/E0.00
Price / Sales0.06
Price / Book0.34
EPS0.07
Book Value1.53
Revenue (TTM)1.32B
Gross Profit (TTM)597.57M
EBITDA152.49M
Profit Margin5.71%
Operating Margin6.60%
Return on Equity4.22%
Return on Assets2.15%
Shares Outstanding147.89M
Shares Float48.32M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%